ST. PAUL, Minn. (AP) -- 3M Co. said Friday it acquired assets of Zargis Medical Corp., which makes FDA-approved software used to classify heart murmurs.
3M previously owned an equity stake in Zargis, and the companies had a marketing and distribution alliance.
3M said Zargis' products include software that can diagnose heart murmurs during both systolic and diastolic phases of the heartbeat, or the periods when the heart contracts and then expands. While some heart murmurs are harmless, the condition can also indicate problems like heart valve disease.
In the deal, 3M is acquiring Zargis' TeleSteth and StethAssist software and Zargis Cardioscan heart sound analysis software.
Shares of 3M rose 32 cents to $93.82 by early afternoon.